Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registryAdrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher, Socorro Alforja, Pierre-Henry Gabrielle, Javier Zarranz-Ventura, Martin Guillemin, Samantha Fraser-Bell, Ricardo P Casaroli Marano, Jennifer Arnold, Ian L McAllister, Louise O'Toole, Mark C Gillies, Daniel Barthelmes, Hemal Mehta
12 March 2021
Comparison of clinical outcomes of conbercept versus ranibizumab treatment for retinopathy of prematurity: a multicentral prospective randomised controlled trialZhenquan Wu, Jinfeng Zhao, Waiching Lam, Mingmin Yang, Lu Chen, Xuelin Huang, Meirong Wei, Hui Yang, Fan Lv, Fuyan Zhang, Jian Zeng, Guo-Ming Zhang
26 February 2021
Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidenceVincent Daien, Robert P Finger, James S Talks, Paul Mitchell, Tien Y Wong, Taiji Sakamoto, Bora M Eldem, Jean-François Korobelnik
31 October 2020
Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyesThomas Ciulla, John S Pollack, David F Williams
14 October 2020
Ten-year survival trends of neovascular age-related macular degeneration at first presentationCristina Arpa, Hagar Khalid, Shruti Chandra, Siegfried Wagner, Katrin Fasler, Livia Faes, Pakinee Pooprasert, Reena Chopra, Gabriella Moraes, Konstantinos Balaskas, Pearse A Keane, Sobha Sivaprasad, Dun Jack Fu
3 October 2020
Multicentre study of 4626 patients assesses the effectiveness, safety and burden of two categories of treatments for central retinal vein occlusion: intravitreal anti-vascular endothelial growth factor injections and intravitreal Ozurdex injectionsRichard Gale, Claire Gill, Maria Pikoula, Aaron Y Lee, Rachel L W Hanson, Spiros Denaxas, Catherine Egan, Adnan Tufail, Paul Taylor
22 September 2020
Brolucizumab: the road aheadAshish Sharma, Nilesh Kumar, Francesco Bandello, Baruch D Kuppermann, Anat Loewenstein, Carl D Regillo
22 August 2020
Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laserRichard Gale, Maria Pikoula, Aaron Y Lee, Spiros Denaxas, Catherine Egan, Adnan Tufail, Paul Taylor, Toks Richard Clare Christopher Usha Alison Narendra Louise Haralabos Sheena Faruque Colin Rehna Vineeth Peck-Lin Aires Andrew Sajjad Geeta Raj Salim Helen Sudeshna Ashish Bobby James Elizabeth Akerele Antcliff Bailey Brand Chakravarthy Davis Dhingra Downey Eleftheriadis George Ghanchi Jones Khan Kumar Lip Lobo Lotery Mahmood Menon Mukherjee Natha Palmer Patra Patwardhan Paul Talks Wilkinson, Toks Akerele, Richard Antcliff, Clare Bailey, Christopher Brand, Usha Chakravarthy, Alison Davis, Narendra Dhingra
See the full list of authors12 June 2020
Cardiovascular risk in patients receiving ranibizumab for exudative age-related macular degeneration: a nationwide self-controlled case-series studyHa-Lim Jeon, Seong Jun Byun, Nicole L Pratt, Janet Sultana, Sang Jun Park, Ju-Young Shin
10 June 2020
Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year resultsJohn F. Payne, Charles C. Wykoff, W. Lloyd Clark, Beau B. Bruce, David S. Boyer, David M. Brown, John F Payne, W Lloyd Clark, John A Wells, David L Johnson, Charles C Wykoff, David M Brown, Matthew Benz, Eric Chen, Richard H Fish
See the full list of authors17 April 2020
